Intervention Enhancing Medication Adherence in Stroke Patients: An Integrative Review

Main Article Content

Suebsarn Ruksakulpiwat

Abstract

Objective: This review aimed to systematically identify and analyze randomized controlled trials (RCTs) reported in the literature that were related to interventions targeted at enhancing medication adherence in stroke patients.
Materials and Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) system was applied to present the process flow, including study identification, screening, exclusion, and inclusion. The PubMed electronic database was searched, and the reference lists of relevant studies were reviewed from 2015 until 2020 to identify relevant RCTs.
Results: The results identified nine relevant RCTs, which included a medication-taking reminder mobile application (Medisafe), health empowerment interventions, telehealth education, and motivational interviews as the medication adherence enhancement interventions that have been most often used in the past five years. Furthermore, these RCTs mainly aimed to improve patients' medication adherence, physical activity, and clinical outcome, such as blood pressure and high-density lipoprotein cholesterol.
Conclusion: This integrative review has implications for the heightened recognition of the necessity for interventions aimed at enhancing patients' adherence to their medication, and that could be applied in clinical practice.

Downloads

Download data is not yet available.

Article Details

How to Cite
Ruksakulpiwat, S. (2021). Intervention Enhancing Medication Adherence in Stroke Patients: An Integrative Review . Siriraj Medical Journal, 73(7), 429-444. https://doi.org/10.33192/Smj.2021.57
Section
Original Article

References

1. Chen Y, Wright N, Guo Y, Turnbull I, Kartsonaki C, Yang L, et al. Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0• 5 million Chinese adults. Lancet Glob Health 2020;8(4):e580-e90.
2. Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18(5):459-80.
3. Feng W, Hendry RM, Adams RJ. Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology 2010;74(7):588-93.
4. Coull A, Lovett J, Rothwell P. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004;328(7435):326.
5. Crayton E, Wright AJ, Ashworth M. Improving medication adherence in stroke survivors: the intervention development process. BMC Health Serv Res 2018;18(1):772.
6. Trompet S, Pons D, AJ DEC, Slagboom P, Shepherd J, Blauw GJ, et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci 2007;1100:189-98.
7. Mendis S. Prevention and care of stroke in low-and middle-income countries; the need for a public health perspective. Int J Stroke 2010;5(2):86-91.
8. Pandian JD, Gall SL, Kate MP, Silva GS, Akinyemi RO, Ovbiagele BI, et al. Prevention of stroke: a global perspective. Lancet 2018;392(10154):1269-78.
9. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007;167(6):540-9.
10. Usherwood T. Encouraging adherence to long-term medication. Aust Prescr 2017;40(4):147.
11. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003;60(7):657-65.
12. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes a meta-analysis. Med Care 2002:794-811.
13. Schiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med 2003;114(8):625-30.
14. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med 2012;157(11):785-95.
15. Al AlShaikh S, Quinn T, Dunn W, Walters M, Dawson J. Predictive factors of non-adherence to secondary preventative medication after stroke or transient ischaemic attack: a systematic review and meta-analyses. Eur Stroke J 2016;1(2):65-75.
16. Kamal AK, Shaikh Q, Pasha O, Azam I, Islam M, Memon AA, et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored Short Messaging Service (SMS)-SMS4Stroke study. BMC Neurol 2015;15(1):1-11.
17. Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014(11).
18. Vervloet M, Linn AJ, van Weert JC, De Bakker DH, Bouvy ML, Van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc 2012;19(5):696-704.
19. Chapman RH, Kowal SL, Cherry SB, Ferrufino CP, Roberts CS, Chen L. The Modeled Lifetime Cost‐Effectiveness of Published Adherence‐Improving Interventions for Antihypertensive and Lipid‐Lowering Medications. Value Health 2010;13(6):685-94.
20. Julius RJ, Novitsky Jr MA, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract 2009;15(1):34-44.
21. Van Dulmen S, Sluijs E, Van Dijk L, De Ridder D, Heerdink R, Bensing J, et al. Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion. BMC Health Serv Res 2008;8(1):47.
22. Liberati A, Altman D, Tetzlaff J, Mulrow C, Gøtzsche P, Ioannidis J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6(7):e1000100.
23. Morawski K, Ghazinouri R, Krumme A, Lauffenburger JC, Lu Z, Durfee E, et al. Association of a smartphone application with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial. JAMA Intern Med 2018;178(6):802-9.
24. Sit JW, Chair SY, Choi KC, Chan CW, Lee DT, Chan AW, et al. Do empowered stroke patients perform better at self-management and functional recovery after a stroke? A randomized controlled trial. Clin Interv Aging 2016;11:1441-50.
25. Wan LH, Zhang XP, Mo MM, Xiong XN, Ou CL, You LM, et al. Effectiveness of Goal-Setting Telephone Follow-Up on Health Behaviors of Patients with Ischemic Stroke: A Randomized Controlled Trial. J Stroke Cerebrovasc Dis 2016;25(9):2259-70.
26. Su Q, Li C, Long F, Chen B, Wan Z, Wu Y, et al. Effects of a health promotion program on medication adherence to antiplatelet therapy among ischemic stroke patients in Hainan Province, China. Vascular 2017;25(3):242-8.
27. Wan LH, Zhang XP, You LM, Ruan HF, Chen SX. The Efficacy of a Comprehensive Reminder System to Improve Health Behaviors and Blood Pressure Control in Hypertensive Ischemic Stroke Patients: A Randomized Controlled Trial. J Cardiovasc Nurs 2018;33(6):509-17.
28. Barker-Collo S, Krishnamurthi R, Witt E, Feigin V, Jones A, McPherson K, et al. Improving Adherence to Secondary Stroke Prevention Strategies Through Motivational Interviewing: Randomized Controlled Trial. Stroke 2015;46(12):3451-8.
29. Kamal AK, Khalid W, Muqeet A, Jamil A, Farhat K, Gillani SRA, et al. Making prescriptions "talk" to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study). PLoS One 2018;13(12):e0197671.
30. Kamal AK, Shaikh Q, Pasha O, Azam I, Islam M, Memon AA, et al. A randomized controlled behavioral intervention trial to improve medication adherence in adult stroke patients with prescription tailored Short Messaging Service (SMS)-SMS4Stroke study. BMC Neurol 2015;15:212.
31. Sajatovic M, Tatsuoka C, Welter E, Colon-Zimmermann K, Blixen C, Perzynski AT, et al. A Targeted Self-Management Approach for Reducing Stroke Risk Factors in African American Men Who Have Had a Stroke or Transient Ischemic Attack. Am J Health Promot 2018;32(2):282-93.
32. Parikh A, Gupta K, Wilson AC, Fields K, Cosgrove NM, Kostis JB. The effectiveness of outpatient appointment reminder systems in reducing no-show rates. Am J Med 2010;123(6):542-8.
33. Chiaranai C. Patient Reminder Program: An Effective Technology Improving Patient Outcome. J. HEALTH Sci 2014;2:185-93.
34. Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med 2002;25(4):355-72.
35. Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ 2008;34(4):692-7.
36. Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, et al. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006;29(9):1997-2002.
37. Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr 2002;29:S2-S10.
38. Roberts KJ. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDS 2000;14(3):155-68.
39. Wu J-R, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am 2008;43(1):133-53.
40. Nair KV, Belletti DA, Doyle JJ, Allen RR, McQueen RB, Saseen JJ, et al. Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey. Patient Prefer Adherence 2011;5:195.
41. Olthoff CM, Hoevenaars JG, van den Borne BW, Webers CA, Schouten JS. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol 2009;247(2):235.
42. Bregnballe V, Schiøtz PO, Boisen KA, Pressler T, Thastum M. Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents. Patient Prefer Adherence 2011;5:507.
43. Lawson EF, Hersh AO, Applebaum MA, Yelin EH, Okumura MJ, von Scheven E. Self-management skills in adolescents with chronic rheumatic disease: a cross-sectional survey. Pediatr Rheumatol Online J 2011;9(1):35.
44. Zelikovsky N, Schast AP, Palmer J, Meyers KE. Perceived barriers to adherence among adolescent renal transplant candidates. Pediatr Transplant 2008;12(3):300-8.
45. Kamal AK, Shaikh QN, Pasha O, Azam I, Islam M, Memon AA, et al. Improving medication adherence in stroke patients through Short Text Messages (SMS4Stroke)-study protocol for a randomized, controlled trial. BMC Neurol 2015;15(1):157.
46. Kendall J. Designing a research project: randomised controlled trials and their principles. EMJ. 2003;20(2):164.
47. Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (Clinical research ed) 2013:346.
48. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux P, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012;10(1):28-55.
49. Cramer H, Haller H, Dobos G, Lauche R. A systematic review and meta-analysis estimating the expected dropout rates in randomized controlled trials on yoga interventions. Evid Based Complement Alternat Med 2016;2016.
50. Dixon LJ, Linardon J. A systematic review and meta-analysis of dropout rates from dialectical behaviour therapy in randomized controlled trials. Cogn Behav Ther 2020;49(3):181-96.
51. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev 2019.
52. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487-97.
53. Wagner J, Justice A, Chesney M, Sinclair G, Weissman S, Rodriguez-Barradas M. Patient-and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol 2001;54(12):S91-S8.
54. Alcoba M, Cuevas MJ, Perez-Simon M-R, Mostaza J-L, Ortega L, de Urbina JO, et al. Assessment of adherence to triple antiretroviral treatment including indinavir: role of the determination of plasma levels of indinavir. J Acquir Immune Defic Syndr 2003;33(2):253-8.
55. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005:521-30.
56. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006;333(7557):15.
57. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) 2011;30(1):91-9.
58. Strandbygaard U, Thomsen SF, Backer V. A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study. Respir Med 2010;104(2):166-71.